PERKINS CAPITAL MANAGEMENT INC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 884300
Institutional-grade research for retail investors

13F Reported Value

$106.7M

Holdings

86

Latest Filing

2026-03-31

Filing Quarter

Q1 2026

Portfolio Overview

PERKINS CAPITAL MANAGEMENT INC disclosed 86 positions worth $106.7M in its Form 13F-HR for Q1 2026, led by $NTRA (Natera, Inc.) at 8.3% of the equity portfolio, followed by $LLY and $AXGN. During the quarter the fund opened 4 new positions and exited 9 — including a new stake in $TLSI and a full exit from $APPS. The portfolio is most concentrated in Healthcare (63.3% of disclosed assets). All figures are sourced directly from PERKINS CAPITAL MANAGEMENT INC’s Form 13F-HR filing with the SEC under CIK 884300.

Sector Allocation

HealthcareTechnologyCommunication ServicesFinancialsMaterialsEnergy

AUM History

Top Equity Holdings by Value

Quarterly Activity — Q1 2026

Click any card to unlock

Top Holdings

AI Quality Scored

Unlock AI quality scores for every holding

32-signal composite ranking on each of PERKINS CAPITAL MANAGEMENT INC's 86 positions.

Showing top 10 of 86 holdings.

Sector Allocation

Healthcare

$67.5M

Technology

$30.0M

Communication Services

$2.5M

Financials

$2.0M

Materials

$1.6M

Energy

$1.3M

Consumer Discretionary

$930,280

Industrials

$490,304

Full Holdings — PERKINS CAPITAL MANAGEMENT INC (Q1 2026)

All 86 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.

#TickerCompanyValueWeightQoQQuality
1NTRA$NTRANatera, Inc.$8.9M8.3%-1%46.4
2LLY$LLYELI LILLY & Co$8.1M7.6%-2%89.3
3AXGN$AXGNAxogen, Inc.$5.6M5.2%-26%38
4IDXX$IDXXIDEXX LABORATORIES INC /DE$5.5M5.1%+0%73.6
5MSFT$MSFTMICROSOFT CORP$4.2M4.0%-7%83.7
6BFLY$BFLYButterfly Network, Inc.$3.8M3.5%+1%29.5
7CIEN$CIENCIENA CORP$3.4M3.2%+0%70.7
8MDXH$MDXHMDxHealth SA$3.4M3.2%+7%
9AMD$AMDADVANCED MICRO DEVICES INC$3.2M3.0%-12%78.8
10QUIK$QUIKQUICKLOGIC Corp$2.9M2.7%+11%
11LMAT$LMATLEMAITRE VASCULAR INC$2.8M2.6%-11%69.1
12OOMA$OOMAOOMA INC$2.6M2.5%-1%51.1
13VCYT$VCYTVERACYTE, INC.$2.4M2.3%-0%59.5
14ABT$ABTABBOTT LABORATORIES$2.1M2.0%-4%67
15ATEC$ATECAlphatec Holdings, Inc.$1.9M1.8%+0%37.7
16ONDS$ONDSOndas Inc.$1.8M1.7%-0%31.8
17CYRX$CYRXCryoport, Inc.$1.7M1.6%-0%59.7
18NEOG$NEOGNEOGEN CORP$1.7M1.6%-1%36.9
19PERI$PERIPerion Network Ltd.$1.6M1.5%+13%
20PSNL$PSNLPersonalis, Inc.$1.5M1.4%+0%15.7
21MGNI$MGNIMAGNITE, INC.$1.4M1.3%-2%42.6
22LUCD$LUCDLucid Diagnostics Inc.$1.3M1.2%+0%
23INGN$INGNInogen Inc$1.2M1.2%-8%35.5
24INUV$INUVInuvo, Inc.$1.2M1.1%-1%35.2
25CXDO$CXDOCrexendo, Inc.$1.2M1.1%+0%59.7
26BLZE$BLZEBackblaze, Inc.$1.2M1.1%+22%36.9
27ABBV$ABBVAbbVie Inc.$1.2M1.1%-9%59.3
28NMTC$NMTCNEUROONE MEDICAL TECHNOLOGIES Corp$1.1M1.1%+0%
29PFE$PFEPFIZER INC$1.0M0.9%-4%69
30GILD$GILDGILEAD SCIENCES, INC.$1.0M0.9%-13%77.8
31NEO$NEONEOGENOMICS INC$982,0370.9%-7%34.6
32MRK$MRKMerck & Co., Inc.$932,2470.9%-11%70.9
33TLSI$TLSITriSalus Life Sciences, Inc.$920,4040.9%NEW28.3
34ZETA$ZETAZeta Global Holdings Corp.$889,9280.8%-1%53.6
35SPAI$SPAISafe Pro Group Inc.$881,0620.8%NEW
36TELA$TELATELA Bio, Inc.$879,3630.8%+1%24.9
37CDXS$CDXSCODEXIS, INC.$859,8250.8%-0%11.3
38USIO$USIOUsio, Inc.$800,2020.8%-1%35.3
39ELUT$ELUTELUTIA INC.$794,7380.7%-3%
40CPSH$CPSHCPS TECHNOLOGIES CORP/DE/$750,1870.7%-1%40.5
41ATRC$ATRCAtriCure, Inc.$744,6330.7%-5%47.6
42VTRS$VTRSViatris Inc$741,6310.7%-5%47.1
43PROF$PROFProfound Medical Corp.$740,5340.7%+0%
44SKYT$SKYTSkyWater Technology, Inc$723,6240.7%-80%68
45BKSY$BKSYBlackSky Technology Inc.$723,3500.7%+0%15.7
46AAPL$AAPLApple Inc.$672,5430.6%-43%76.1
47USB$USBUS BANCORP DE$652,7250.6%+0%71.4
48BDSX$BDSXBIODESIX INC$649,3530.6%+0%32.3
49COP$COPCONOCOPHILLIPS$640,2000.6%-8%74.8
50CELC$CELCCelcuity Inc.$616,3560.6%-16%
51ANIP$ANIPANI PHARMACEUTICALS INC$602,9720.6%-7%68.6
52TGT$TGTTARGET CORP$593,8800.6%+0%53.1
53BLNE$BLNEBeeline Holdings, Inc.$575,7500.5%+0%
54OWLT$OWLTOwlet, Inc.$545,3280.5%+4%32.5
55T$TAT&T INC.$463,6080.4%-29%71.9
56VZ$VZVERIZON COMMUNICATIONS INC$457,2210.4%-17%71.6
57BMY$BMYBRISTOL MYERS SQUIBB CO$450,6290.4%-12%70.1
58BP$BPBP PLC$432,4000.4%+0%
59DCI$DCIDONALDSON Co INC$390,4020.4%+5%64.7
60CSTL$CSTLCASTLE BIOSCIENCES INC$378,4380.3%-45%37.7
61PLUS$PLUSEPLUS INC$376,2500.3%+0%56
62NXPI$NXPINXP Semiconductors N.V.$354,3480.3%-22%
63DGII$DGIIDIGI INTERNATIONAL INC$353,4500.3%+0%56.3
64FAST$FASTFASTENAL CO$336,4000.3%+0%73.5
65VCEL$VCELVericel Corp$336,1760.3%-2%46
66GIS$GISGENERAL MILLS INC$330,3270.3%-15%64.1
67ELWT$ELWTElauwit Connection, Inc.$329,1150.3%+0%
68LFVN$LFVNLifevantage Corp$325,9780.3%+0%49.6
69VERI$VERIVeritone, Inc.$309,7820.3%-10%13.2
70JNJ$JNJJOHNSON & JOHNSON$293,3280.3%-25%72.8
71BLFS$BLFSBIOLIFE SOLUTIONS INC$238,5000.2%+0%41.7
72STX$STXSeagate Technology Holdings plc$215,4680.2%NEW
73XGN$XGNEXAGEN INC.$215,3880.2%+287%25.2
74MRNA$MRNAModerna, Inc.$203,2000.2%NEW15.9
75XOM$XOMEXXON MOBIL CORP$202,5740.2%-30%61.8
76ASUR$ASURASURE SOFTWARE INC$202,1000.2%+0%
77APYX$APYXApyx Medical Corp$154,9800.1%-51%19.3
78AIRG$AIRGAIRGAIN INC$121,0000.1%+0%19.2
79OPRX$OPRXOptimizeRx Corp$99,9020.1%-9%51.3
80PBYI$PBYIPUMA BIOTECHNOLOGY, INC.$79,8750.1%+0%52.5
81RMTI$RMTIROCKWELL MEDICAL, INC.$62,8550.1%+4%20.5
82IRIX$IRIXIRIDEX CORP$55,8530.1%+34%24.3
83LUNG$LUNGPulmonx Corp$52,8900.1%-16%23.9
84SOPH$SOPHSOPHiA GENETICS SA$51,9750.1%+0%
85DYAI$DYAIDYADIC INTERNATIONAL INC$39,4010.0%-86%
86ARAY$ARAYACCURAY INC$20,3750.0%-39%22.7

New Positions (4)

TLSI$TLSI TriSalus Life Sciences, Inc.$920,404
SPAI$SPAI Safe Pro Group Inc.$881,062
STX$STX Seagate Technology Holdings plc$215,468
MRNA$MRNA Moderna, Inc.$203,200

Exited Positions (9)

APPS$APPS Digital Turbine, Inc.
VELO$VELO Velo3D, Inc.
DAWN$DAWN Day One Biopharmaceuticals, Inc.
INTC$INTC INTEL CORP
COST$COST COSTCO WHOLESALE CORP /NEW
TCMD$TCMD TACTILE SYSTEMS TECHNOLOGY INC
HAIN$HAIN HAIN CELESTIAL GROUP INC
CVRX$CVRX CVRx, Inc.
FLEXSHOPPER INC

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

Available Analysis

13F Pro tracks comprehensive institutional data for PERKINS CAPITAL MANAGEMENT INC including:

Full 13F portfolio with all holdings
Quarter-over-quarter position changes
Accumulation & distribution patterns
Sector allocation breakdown
Historical portfolio evolution
New positions & complete exits
Concentration analysis
Peer comparison with similar funds
AI-powered portfolio insights

Track PERKINS CAPITAL MANAGEMENT INC's Full Portfolio

See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for PERKINS CAPITAL MANAGEMENT INC and 8,700+ other institutional investors.

View Pricing

Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

AI-Powered Hedge Fund Analysis: PERKINS CAPITAL MANAGEMENT INC

13F Pro is an AI hedge fund tracker and stock research platform. For PERKINS CAPITAL MANAGEMENT INC (SEC CIK: 884300), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in PERKINS CAPITAL MANAGEMENT INC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.